Want to join the conversation?
James Medvedeff of Cowen and Company probes on newer products coming in, in the accessory group and the mix lowering GM. $VOXX CEO Pat Lavelle said the company had some one-time adjustments which effected the accessory group, which was 80 BP overall in 4Q16. $VOXX believes the bottom line is consistent with what is there in the accessory group.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.